Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Naproxen sodium

Available EU dossier in development

Offer available for: licensing

Pharmaceutical form and dosage: 225 mg


Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)


Therapeutic target:

- Arthritis / Rheumato

Action: Anti-inflammatory and antirheumatic products - analgesics (Rheumato)

Company Contact


Corporate data: PharmaRegistrations
Belgium

Contact for this offer: Lieve Vermassen

Or check this company's:


Full Description:
Naproxen sodium dossier:
-New readily available for licensing
-Available: IV/2002
-Stability: 25C: 24 months + continued, 40C: 6 months


Availability and Market information:

Status: Development


Market information

Other Market Info:


Patent Information:
Name: Aleve = Naprosyne
Patent info: Expired


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search